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Abstract 
Background 
Resource constrained primary care environments in Africa need cost-effective 
models of patient education to combat the emerging epidemic of non-communicable 
chronic diseases. This study aimed to evaluate the cost-effectiveness of a group 
diabetes education programme delivered by health promoters with a guiding 
style,in community health centres in the Western Cape, South Africa. 
Method 
The effectiveness of the education programme was derived from the outcomes of a 
pragmatic cluster randomised controlled trial (RCT). Incremental operational costs 
of the intervention, as implemented in the trial, were calculated. All these data were 
entered into a Markov micro-simulation model to model outcomes and cost-
effectiveness expressed as an Incremental Cost Effectiveness Ratio (ICER).Data 
predicting risk of death from stroke and ischaemic heart disease in this model was 
derived from South African surveys. 
Results: 
The only significant effect from the RCT was a reduction in blood pressure at 1-year 
(systolic blood pressure -4.65mmHg (-9.18- -0.12) and diastolic blood pressure -
3.30mmHg (-5.35 - -1.26)). The ICER for the intervention, based on the assumption 
that the costs would recur every year and the effect be maintained, was 1862.  
Conclusion: 
An ICER of less than 10000 for medical intervention in South Africa is considered 
cost-effective. A structured group education programme performed by mid-level 
trained healthcare workers with a guiding style at community health clinics, for the 
management of Type 2 diabetes in the Western Cape, South Africa is therefore cost-
effective. 
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Introduction 
The burden of non-communicable chronic diseases is high in low and middle-
income countries and is predicted to increase with the aging of populations, 
urbanisation and globalisation of risk factors.1Diabetes is an important disease 
because it contributes significantly to this burden of non-communicable chronic 
disease.2South Africa has a large number of people living with diabetes and this 
number is predicted to increase substantially over the next few years.1The 
prevalence rate of diabetes in parts of Cape Town has been reported to be as high as 
33%, although self-reported prevalence rates for diabetes in South Africa have been 
reported at 2.4% in men and 3,7% in women.1In 2000 the adult mortality associated 
with diabetes was about 4.3% of deaths in South Africans over the age of 30.3In 
South Africa diabetes often affects working age people, as well as the elderly, and 
therefore can also have significant economic consequences.4In 2011 the prevalence of 
diabetes in South Africa was estimated to be 6.5% in the age group 20-79years.5 
Effective management of diabetes requires medication as well as self-care and 
lifestyle change from the patient. A holistic and integrated approach to the 
management of chronic diseases is needed in primary health care. To meet the 
challenges of diabetes in primary health care, we will have to strengthen both 
pharmacological and psychosocial interventions, as well as long term follow up with 
regular monitoring and promotion of adherence to treatment.6 
Poor diabetes management is associated with deficiencies in knowledge and 
selfcare.1Behaviour change counselling to promote self-care and lifestyle change has 
not been done well in our setting for various reasons. Some of these reasons include 
a lack of counselling space, lack of support, lack of knowledge, poor counselling 
skills, time pressure and patient’s perceived resistance to change as a result 
ofcounselling.22 The majority of people with diabetes are looked after by nurses in 
the public sector at health centres and clinics.6 In the Western Cape although the 
technical quality of care has been improving, there is still little attention given to a 
structured and comprehensive education programme that will work in our context. 
Patients have a right to understand their diagnosis and how to manage their 
condition and health services should provide health education and counselling. 
However in a climate of scarce resources, policy-makers need to know which 
interventions represent value for money.8The development of appropriate models of 
behaviour change counselling in our context that can be scaled up will depend on 
their cost-effectiveness.  
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The incremental cost-effectiveness ratio (ICER) is the gold standard for comparing 
different treatment interventions by analysing cost and benefit. No cost-effectiveness 
studies regarding behaviour change counselling in diabetes have been performed in 
South Africa. Systematic reviews by the American Diabetes Association(ADA) found 
that lifestyle interventions for the prevention and management of diabetes mellitus, 
cardiovascular disease and other chronic diseases were cost-effective.8,9,10,11 
In low resource settings group approaches to patient education may make sense, 
given the large number of patients with diabetes and the relatively low number of 
health workers. A systematic review of group diabetes education suggests that it can 
be effective at improving glycaemic control, improving blood pressure, helping with 
weight loss and reducing the need for medication.15 The studies in this review, 
however, were from high income settings and mostly used expensive health workers 
such as dieticians. In a recent local study, from the Eden District in the Western 
Cape, group diabetes education was shown to lead to significant improvement in 
self-care activity in the form of adherence to diabetes diet, physical activity, foot care 
and the perceived ability to teach others. These results were obtained through 
measuring the effect on self-care activities, immediately before and after education.7 
A pragmatic cluster randomised control trial(RCT) that evaluated group education 
of diabetes by health promoters with a guiding style (derived from motivational 
interviewing) was also recently completed in the public sector primary care services 
in Cape Town. Implementation of the model of diabetes group education from this 
RCT will depend on how effective it is and the costs involved in rolling it out. The 
RCT measured effectiveness and this study will measure the costs involved and 
analyse the cost effectiveness using the ICER. As health care costs have continued to 
rise, many new clinical trials are attempting to integrate ICER into results to provide 
more evidence of potential benefit.12 
Several studies have also been completed on different forms of motivational 
interviewing(MI) in the prevention and management of  type 2 diabetic mellitus 
patients in European and American settings.9,10,14,15,16Many of these include measures 
of cost effectiveness.4,9,13 They report mixed findings with regards to motivational 
interviewing(MI). It can be used as an effective way of enhancing diabetes treatment, 
but is more effective when targeted to a specific behaviour.14The majority of the 
studies found positive results for the effects of MI on psychological, physiological, 
and lifestyle change outcomes.14,15,16In 2009 four meta-analyses on the effectiveness 
and application of motivational interviewing found MI is 10-20% significantly more 
effective than no treatment and generally equal to other available therapies (such as 
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cognitive behavioural therapy). Its application ranges from a variety of problems 
such as substance use( alcohol, marijuana, tobacco and other drugs) to reducing 
risky behaviours in chronic disease and increasing client engagement in 
treatment.17None of these studies reported on the cost-effectiveness of group 
motivational interviewing performed by midlevel health care workers. Indeed, no 
trials of group behaviour change counselling for diabetes by mid-level workers has 
previously been reported in our setting – a middle income African country.18 
Aims and objectives 
The aim of the study was to determine the cost-effectiveness of a group education 
programme delivered by health promoters with a guiding style in community health 
centres in Cape Town. Specific objectives were to: 
Objective 1: Evaluate the start-up costs of the programme 
Objective 2: Evaluate the operational costs of running the programme  
Objective 3: Compare costs to the measured effectiveness of the programme derived 
from the larger RCT and report on the ICER 
Objective 4: To make recommendations to the Department of Health on the cost 
effectiveness of the programme 
Methods 
Study design 
This was a cost-effectiveness study utilising the ICER as an outcome measure. 
Overview of the randomised control trial 
The design of the pragmatic clustered RCT has been published fully 
elsewhere.14There were 17 randomly selected intervention and 17 control sites, with 
860 patients with type 2 diabetes in the control and 710 in the intervention sites. The 
control sites offered usual care, while the intervention sites offered 4 sessions of 
group diabetes education, a month apart, delivered by a health promoter (mid-level 
health worker). “Health promoters recruited from the district health services were 
trained over a total of 6 days to deliver each session within the facility, using a 
guiding style of communication based on motivational interviewing principles and 
skills. Resource materials for group activities were developed for each session and 
the training manual was published.  Where necessary resource materials were made 
available in English, Afrikaans and Xhosa.”12 It included leaflets and information 
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sheets on foot care, goal setting, alcohol use and smoke cessation that were supplied 
by each HPO for the patients to take home. The intervention consisted of four 60 
minute sessions. These group education sessions focused on understanding diabetes, 
living a healthy lifestyle, understanding the medication and avoiding 
complications.12Participants were measured at baseline and at 12 months. Primary 
outcomes included diabetes self-care activities, 5% weight loss, and HbA1c 
reduction of 1%.  Secondary outcomes included self-efficacy, locus of control, mean 
blood pressure, mean weight loss, mean waist circumference, mean HbA1c, mean 
total cholesterol and quality of life. The setting of the study was community health 
centres in the Cape Town Metropolitan area that serve the uninsured majority 
population within the public sector. The only significant effect from the RCT was a 
reduction in blood pressure at 1-year (systolic blood pressure -4.65mmHg (-9.18- -
0.12)and diastolic blood pressure -3.3mmHg(-5.35 - -1.26)). 
Data collection 
To ensure that the costs were fully understood I conducted interviews with key 
informants at the University and within the Metropolitan District Health Services. 
Key informants were purposefully selected for their knowledge of the costs involved 
and the financial systems of the district health services. The following people were 
consulted: study investigators, health promoters, facility managers, district level 
financial officers and managers. These interviews were used to check that the 
researchers had correctly identified all the costs that would be involved in 
implementing the educational programme. These interviews were not regarded as 
qualitative data and no formal analysis was performed.  
Data was then collected from the financial records of the RCT within the Division of 
Family Medicine and Primary Care, Stellenbosch University. Costs related to the 
research study and which would not be part of implementing the educational 
programme in normal service delivery were excluded. Only incremental costs that 
would add additional costs to what is already being paid for by the health services 
were considered. 
Data analysis 
All numerical data were checked and captured on an Excel spreadsheet. Data on the 
patients and the outcome measures were made available by the principal 
investigator from the RCT. Data on cost was then entered into a cost-effectiveness 
model for cardiovascular disease that had been created by Prof Tom Gaziano at 
Harvard University in collaboration with the Chronic Disease Initiative for Africa 
(CDIA) in Cape Town. 
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Research by the CDIA is currently underway to assess the economic impact of 
prevention and management interventions for chronic diseases. The aim is to 
develop a Cardiovascular Disease (CVD) prevention and management model that 
will allow the prediction of CVD events and which could be used in cost-
effectiveness analyses of screening and intervention studies. State-transition 
simulation models have been developed to assess the cost-effectiveness of 
interventions. 23 The model evaluates the Incremental Cost Effectiveness Ratio and 
cost per Quality Adjusted Life Years (QALY) saved. The incremental cost-
effectiveness ratio (ICER) is commonly used in health economics to provide a 
practical approach to decision making regarding health interventions. It is 
specifically used in cost-effectiveness analysis and is the ratio of the incremental 
increase in costs, measured in US$, to the benefits of a therapeutic intervention, 
measured in QALYs saved. By using this ratio, comparison can be made between 
treatment modalities to determine which provides a more cost-effective treatment.19 
The cost-effectiveness model developed by Harvard University is based on the 
Markov micro-simulation model, which is particularly suited to modeling chronic 
disease, and is used for economic evaluation of healthcare interventions. Markov 
models have been used for several years to support health service decision-making. 
Its primary use is in economic-evaluation, but it can also be applied 
epidemiologically. One of the strengths of Markov modelling is that it can handle 
both costs and outcomes simultaneously. It is well suited for modeling disease 
progression over time.20 In our study the analysis modeled the outcomes of a clinical 
trial to project the longer-term cost-effectiveness of interventions from a payer 
perspective.13 
The model incorporates all basic CVD risk factors (age, sex, smoking, diabetes 
mellitis (DM), blood pressure (BP), cholesterol or body mass index (BMI) if 
cholesterol is not available) and predicts future rates of angina, myocardial 
infarction, or stroke and death for any population. Data was used from the initial 
RCT to explore predicted changes in future CVD events based on the effect shown 
by the RCT. The cost of achieving a reduction in risk factors (in this case BP) and the 
likely long term benefit of this in terms of avoiding future deaths from CVD events 
can then be modeled. 
The baseline data from the RCT, which measured the risk factor profile of the study 
population, was used to generate a theoretical population of 1000 000 people with 
diabetes in the model. The incremental costs of implementing the intervention over a 
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1-year period were also entered into the model. The theoretical population was 
created to share the same risk factor profile as the study population. The model was 
then used to predict future mortality from CVD events over 10-years, 30-years and 
eventually until they die. The model could also compute future costs related to the 
intervention and to the treatment of CVD events. The model was then able to 
compare the results for a population with no intervention vs. a population with the 
intervention from the RCT that had the decreased BP. From this comparison the 
model was able to determine the incremental costs and the QALYs saved (utility)and 
to calculate the ICER. 
Since the trial only lasted one year, we ran four different scenarios for what might 
happen in subsequent years and calculated results for each scenario: 
1. The intervention is repeated each year and the benefits persist over time.  
2. The intervention is performed once and the benefits only achieved in that year.  
3. The intervention is performed once, but the benefits persist indefinitely. 
4. The intervention is performed once and the benefits gradually decrease over 3-
years. 
There are an infinite number of scenarios that are possible, but these are the most 
plausible covering the full spectrum of possibilities. 
Results 
The RCT recruited 1570 Type2 diabetic patients and there were 710 patients 
recruited in the intervention arm and 860 recruited in the control arm of this study. 
Figure 1 shows a schematic representation of the study population and sample at 
baseline and follow up. 
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Figure 1: Flowchart of study groups 
Table I shows the clinical and biochemical data from the RCT that were collected at 
baseline. Diabetics were generally poorly controlled with regards to HbA1c, total 
cholesterol, blood pressure, and waist circumference. 
Table I: Clinical and biochemical data collected at baseline (N=1570) 
 Control Intervention 
Clinical measurements Mean (95%CI) Mean (95%CI) 
HbA1c (%) 9.3 (9.2-9.5) 8.9 (8.7-9.1) 
HbA1c (mmol/mol) 78 (77-80) 74 (72-76) 
Cholesterol (mmol/l) 4.9 (4.8-5.0) 5.0 (4.9-5.1) 
Weight (Kg) 83.9 (82.7-85.2) 84.4 (83.0-85.8) 
Waist circumference (cm) 100.3 (99.3-101.3) 101.9 (100.9-103.0) 
Diastolic blood pressure 
(mmHg) 
85.6 (84.7-86.5) 85.9 (85.1-86.8) 
Systolic blood pressure 
(mmHg) 
137.1 (135.4-138.7) 140.2 (138.5-141.8) 
Level of control n (%) n (%) 
HbA1c < 7% / 53 mmol/mol 134 (15.6) 141 (19.9) 
Cholesterol < 5.0 mmol/l 458 (53.3) 342 (48.2) 
Diastolic BP < 80 mmHg 289 (33.6) 212 (29.9) 
Systolic BP < 130 mmHg 345 (40.1) 245 (34.5) 
Waist circumference – Females 
< 82 cm 
40/650 (6.2) 32/508 (6.3) 
Waist circumference – Males 80/209 (38.3) 57/202 (28.2) 
Study population n=1570 
Baseline 
Control group 
n=860 
17 health centres 
12 months 
Control group 
n=475 
17 health centres 
Baseline 
Intervention group 
n=710 
17 health centres 
12 months 
Intervention group 
n=391 
17 health centres 
 11 
 
<94 cm 
Known complications / 
comorbidity 
n (%) n (%) 
Hypertension 715 (83.1) 539 (75.9) 
Hypercholesterolaemia 279 (32.4) 239 (33.7) 
Chronic kidney disease 26 (3.0) 12 (1.7) 
Cataracts 83 (9.7) 67 (9.4) 
Retinopathy 5 (0.6) 40 (5.6) 
Peripheral vascular disease 1 (0.1) 13 (1.8) 
Leg ulcers 36 (4.2) 24 (3.4) 
Neuropathy 12 (1.4) 52 (7.3) 
Amputation 7 (0.8) 8 (1.1) 
Ischaemic heart disease 26 (3.0) 22 (3.1) 
Cardiac failure 35 (4.1) 4 (0.6) 
Stroke 26 (3.0) 20 (2.8) 
Medication n (%) n (%) 
Metformin (mg) 738 (85.8) 595 (83.8) 
Glibenclamide (mg) 115 (13.4) 118 (16.6) 
Gliclazide (mg) 324 (37.7) 268 (37.7) 
Insulin (IU) 228 (26.5) 213 (30.0) 
Hydrochlorthiazide (mg) 438 (50.9) 337 (47.5) 
Enalapril (mg) 492 (57.2) 420 (59.2) 
Amlodipine (mg) 288 (33.5) 276 (38.9) 
Simvastatin (mg) 271 (31.5) 258 (36.3) 
 
Table II shows the baseline results from the RCT that describe levels of self-care 
activities, psychological factors and quality of life. 
Table II: Self-care activities, psychological factors and quality of life at baseline 
(N=1570) 
 Control Intervention 
Self-care activities Mean (CI) Mean (CI) 
Adherence to diet plan (days/week) 4.6 (4.5-4.7) 3.8 (3.7-4.0) 
Exercise (days/week) 2.9 (2.8-3.1) 3.4 (3.2-3.5) 
Foot care (days/week) 5.4 (5.2-5.5) 4.3 (4.1-4.5) 
Adherence to medication 
(days/week) 
6.7 (6.6-6.8) 6.0 (5.9-6.2) 
Smoker n (%) 157/860 (18.3) 130/710 (18.3) 
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Psychological factors   
Self-efficacy score (1-10) 3.4 (3.4-3.5) 3.5 (3.5-3.6) 
Internal locus of control score (1-6) 4.7 (4.6-4.8) 4.7 (4.6-4.8) 
External locus of control score (1-6) 4.3 (4.2-4.4) 4.2 (4.2-4.3) 
Chance locus of control score (1-6) 3.7 (3.6-3.8) 3.4 (3.3-3.5) 
Quality of life   
Physical functioning (Score out of 
100) 
76.7 (75.2-78.3) 74.5 (72.9-76.1) 
Role functioning (Score out of 100) 69.9 (67.9-72.0) 77.3 (75.2-79.4) 
Social functioning (Score out of 100) 57.9 (55.9-59.8) 64.9 (62.5-67.4) 
Mental status (Score out of 100) 59.2 (58.2-60.2) 58.7 (57.6-59.8) 
Health status (Score out of 100) 56.3 (55.5-57.1) 56.2 (55.2-57.3) 
Pain (Score out of 100) 52.2 (50.3-54.1) 56.9 (54.7-59.0) 
 
Table III shows that none of the primary outcomes were achieved, but there was a 
significant reduction in blood pressure at 1-year (systolic blood pressure -4.65mmHg 
(-9.18- -0.12) and diastolic blood pressure -3.3mmHg(-5.35 - -1.26) ,which is likely to 
be clinically significant. This will have an effect on the reduction of risk for 
cardiovascular disease. 
Table III: Results for primary and secondary outcomes 
Outcomes Control 
Mean (CI) 
Intervention 
Mean (CI) 
Difference 
(intervention – 
control) (CI) 
P 
value 
 
Self-care activities     
Physical activity score 4.0 (3.8-4.3) 3.9 (3.6-4.1) -0.25 (-1.13 – 0.63) 0.574 
Adherence to diet plan 
score 
4.8 (4.6-5.0) 4.6 (4.4-4.8) -0.08 (-0.69 – 0.53) 0.802 
Adherence to 
medication score 
6.9 (6.8-6.9) 6.8 (6.7-6.9) 0.01 (-0.13 – 0.15) 0.897 
Foot care score 5.7 (5.5-5.9) 5.5 (5.3-5.7) -0.14 (-0.46 – 0.17) 0.380 
Smoking (%) 99/483 (20.5%) 78/409 (19.1%) -0.01 (-0.04 – 0 .03) 0.800 
Psychological factors     
Self-efficacy score 3.7 (3.6-3.7) 3.7 (3.6-3.7) -0.03 (-0.19 – 0.13) 0.735 
Internal locus of control 
score 
4.8 (4.7-4.8) 4.8 (4.7-4.8) 0.02 (-0.09 – 0.13) 0.711 
External locus of control 
score 
4.5 (4.5-4.6) 4.4 (4.4-4.5) 0.08 (-0.24 – 0.19) 0.283 
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Chance locus of control 
score 
3.8 (3.7-3.9) 3.6 (3.5-3.7) -0.18 (-0.56 – 0.19) 0.344 
Clinical measurements     
HbA1c (%) 8.8 (8.6-9.0)* 8.4 (8.2-8.6)# 0.01 (-0.27 – 0.28) 0.967 
Weight (Kg) 83.5 (81.9-85.2) 83.8 (81.8-85.7) -1.01 (-3.32 – 1.30) 0.392 
Waist circumference 
(cm) 
103.1 (101.9-
104.2) 
103.6 (102.1-
105.1) 
-0.72 (-2.4 – 0.94) 0.396 
Systolic BP (mmHg) 146.1 (143.9-
148.3) 
143.1 (140.6-
145.5) 
-4.65 (-9.18 – -0.12) 0.044 
Diastolic BP (mmHg) 88.2 (87.1-89.4) 85.0 (83.8-86.2) -3.30 (-5.35 - -1.26) 0.002 
Total cholesterol 
(mmol/l) 
4.9 (4.8-5.0) 4.8 (4.7-5.0) -0.13 (-0.27 – 0.01) 0.066 
Quality of life 
measurements 
    
Physical functioning 
score 
26.9 (26.3-27.4) 26.4 (25.8-27.0) -0.34 (-1.87- 1.20) 0.668 
Role functioning score 79.1 (76.7-81.4) 81.7 (79.2-84.2) 2.05 (-3.95 – 8.05) 0.503 
Social functioning score 63.7 (61.0-66.5) 63.2 (60.2-66.2) -0.34 (-10.89 – 10.21) 0.950 
Mental health score 60.2 (59.0-61.4) 60.1 (58.8-61.4) -0.08(-3.86-3.70) 0.966 
General health score 60.0 (59.0-61.0) 58.8 (57.8-59.8) -1.24(-3.03 – 0.57) 0.179 
Pain score 56.0 (53.3-58.7) 57.7 (54.8-60.6) 0.06(-5.96- 6.08) 0.984 
 
Table IV shows a summary of the incremental costs incurred in implementing the 
educational programme from the perspective of the health services. 
Table IV: Summary of the incremental costs 
Incremental cost of Group Diabetes 
Education       
  
Per 
Unit Unit Cost:ZAR 
Salary costs       
Health Promotion Officers 42.49 544 hours 23114.56 
Training costs       
Health promotion officer 42.49 816 hours 34671.84 
Trainer 1 ( Family physician/ MI expert) 437.81 48 hours 21014.88 
Trainer 2  ( Diabetes educator/nurse) 120.7 48 hours 5793.6 
Venue hire 0 0 0 
Refreshments for training 2300 6 13800 
Training manuals 0.3 460 pages 138 
Travel costs for training 0.9 2040 km 1836 
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Education material costs       
Printing Flipchart pages 52.8 17 charts 897.6 
Binding of flipcharts 10 17 charts 170 
MRC food cards 216.6 17 sets 3682.2 
Printing of True/false card packs  15 52.2 17 sets 887.4 
Printing costs 0.3 16320 pages 4896 
Operational costs       
Venue for education 0 0 0 
SMS reminders ( Bulk SMS ) 0.3 4080 SMS 1224 
Patient costs       
Loss of earnings 55 640 patients 35200 
Travel costs per patient 9 6120 (3 trips) 55080 
 
Each health promotion officer (HPO) required training to perform the educational 
sessions. The training course was a total of 8hours per day for 6days and was 
delivered by an expert in motivational interviewing and a specialist nurse in 
diabetes, both of whom were involved for the full duration of the training. The 
training cost for the expert in motivational interviewing was based on a grade 3 
specialist salary and for the nurse from the salary for a specialist diabetes nurse 
educator. No venue costs were incurred for the training as it was performed at the 
University or the Department of Health premises. Each HPO received a 23 page 
training manual and cost was calculated at R0.3 per page. The HPOs also had to 
travel on a daily basis about 10km at R9 by public transport per trip to and from 
training for 6 days.  
The educational materials provided for each of the 17 HPOs for the group sessions 
were as follows: 
 A3 size Flipchart at R52.80 each 
 Ring binding of flipcharts at R10 each 
 MRC food cards at R216.60 per pack 
 Printing of true /false game cards  at R52.20 per pack 
 There were also printing costs involved for leaflets and information sheets on 
foot care, goal setting, alcohol use and smoke cessation that were supplied to 
each HPO for the patients to take home at R0.3 per page. 
Each of the HPOs had 4 groups of 15patients each per CHC and had to do 4 group 
education sessions with each group. The cost calculation assumes that each of the 17 
community health centres has its own full time HPO. The group education sessions 
were each a maximum of 2-hours long. The training and salary cost for the HPOs 
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were calculated by the number of hours involved and the cost per hour of their time, 
which was based on the current average salary package for a HPO. 
Text messages were used to remind patients when to attend each session at R0.3 per 
message. Assuming that all of these patients made use of public transport to attend 
these sessions and that they all lived within a 10km radius ,the cost of transport per 
visit was estimated at R18. As the educational sessions were held as far as possible 
on the same day as their routine follow up visits or medication collection dates many 
of these trips would have been made anyway. 
Many of these patients had a half day loss in earning due to them attending the CHC 
for their chronic disease follow up and for the group education programme. In total 
therefore for the four educational sessions they would have lost the equivalent of 
two days of earnings. From the RCT 74% of the sample were female and 26% were 
male and of these it is estimated that 55% of the working age men  and 43% of 
working age women  were employed.14Overall therefore 20.4 men and 34.4 women 
are likely to each have lost the equivalent of 2-days work. Data from the latest census 
confirms the average monthly income for a working person in the general labour 
market in the Western Cape is R6400 or R320 per day.11Therefore loss of earnings for 
these patients was R640 per person. 
Cost-effectiveness analysis 
Table V and Figure 2 shows the number of deaths that should be prevented by 
implementing the educational intervention using the 4 different scenarios in the cost-
effectiveness model. The two scenarios that assume a persistent benefit for the 
intervention prevent the same number of deaths from CVA and IHD. The scenarios 
that assume a 1-year or gradually reducing 3-year benefit predict that a much 
smaller number of deaths would be prevented. 
Table V: Number of deaths prevented compared to no intervention 
  
  
Annual cost, 
persistent 
benefit 
1 year cost, 
persistent 
benefit 
1 year cost, 1 
year benefit 
1 year cost, 3 
year 
declining 
benefit 
     Total CVA  5481 5481 57 374 
Total IHD  4215 4215 148 427 
CVA=Cerebrovascular accident. IHD=Ischaemic heart disease 
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Figure 2: Graphic illustration of number of deaths prevented by performing the 
intervention in 4 different scenarios taking into consideration how long the 
benefit will last. CVA=Cerebrovascular accident. IHD=Ischaemic heart disease 
 
Table VI shows the ICER for the 4 different scenarios based on the incremental costs 
and deaths averted from stroke and ischaemic heart disease. 
Table VI: Cost effectiveness of scenarios with different intervention costs and 
duration of benefits 
  
Incremental  cost  
($ ) 
Incremental utility 
(QALY) 
ICER 
Annual cost, persistent benefit 125.29 0.0673 1861.66 
1 year cost, persistent benefit -398.49 0.0673 dominant 
1 year cost, 1 year benefit -4.12 0.0044 dominant 
1 year cost, 3 year declining benefit -22.85 0.0095 dominant 
 
Table VI presents an ICER of 1862 $/QALY for the first scenario and finds that the 
other three scenarios were dominant in the sense that less money would be spent (no 
incremental costs) to produce a benefit in terms of QALYs. As there were no 
incremental costs it was not possible to calculate an ICER, although these scenarios 
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are theoretically superior to the first one. The first scenario, however, is the most 
realistic as the health services would expect the intervention to be sustained over 
time if it was implemented. 
Discussion 
The WHO defines ICER as “very cost-effective” if it is less than 1times the per capita 
Gross Domestic Product(GDP) or “cost-effective” if it is less than 3 times the per 
capita GDP. Current GDP per capita for South Africa is 6003.46 United States 
Dollars(USD).31,35 The ICER of this educational programme was 1862. This 
intervention is therefore considered very cost-effective if implemented in South 
Africa.There is currently no other local data available with regards to the ICER of 
educational interventions to improve the management of diabetes in South Africa. 
Systematic reviews, which include studies from other settings, have also found 
educational interventions in the prevention and management of diabetes and 
chronic diseases to be cost-effective.8,9,10,11The World Health Organisation’s (WHO), 
Global Status Report 2011 on non-communicable diseases (NCD) has classified brief 
behaviour change counselling interventions or counselling in primary care as a 
“good buy”. 
According to a systematic review in the Cochrane Library ,group based education 
for people with type2 diabetes is effective at improving fasting blood glucose levels, 
glycated haemoglobin, diabetes knowledge and reducing systolic blood pressure 
levels, body weight and the requirement for diabetes medication.15This RCT in Cape 
Town only impacted on blood pressure and yet was still found to be cost-effective. It 
is possible therefore that group education could be more effective in our context, 
maybe if offered by more qualified professional counsellors, nurses or doctors, 
although these are a scarce resource in our setting. A qualitative process evaluation 
of this intervention showed that the health promoters struggled to find suitable 
space for the group education in the health centres.” In many cases space was 
unsuitable in terms of size or interruptions or was not prioritised by the facility 
management for this purpose. Health promoters and study co-ordinators also 
struggled to communicate with patients regarding the dates and times of 
educational meetings or changes in arrangements. Many patients came from poor 
communities and had no landline or shared their cell phone with other family 
members.”12These factors may have been partly responsible for the poor attendance 
at the educational sessions and have reduced the effect in the study. Another 
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possible explanation is that the health promoters, who were less qualified mid-level 
health workers, were unable to deliver the intervention as effectively. 
The University of Stellenbosch, Division of Family Medicine and Primary Care are 
also in the process of developing an approach to individual brief behaviour change 
counselling that can be offered by primary care providers such as nurses or 
doctors.21This counselling is supported by patient education leaflets that address the 
four main risk factors for NCDs: tobacco smoking, unhealthy diet, physical inactivity 
and harmful alcohol use.21Counselling is based on an approach that uses the 5 As 
(Ask, Alert, Assess, Assist and Arrange) offered again in a guiding style. Other 
research in our context has suggested that a combination of structured group and ad 
hoc individual counselling may be the best approach.2 
Limitations  
The results and assumptions of this cost-effectiveness analyses cannot be applied to 
developed countries. From the data provided by the RCT it lacked data regarding 
BMI  that were not included in the patient data obtained. BMI data had to be 
extrapolated from other South African studies to be used in the cost-effectiveness 
model. All the data used in the model is from South Africa and is thus valid for the 
South African setting. Four assumptions were made about cost-effectiveness through 
modelling  from the intervention are the ones most plausible for the intervention. In 
cost-effectiveness analyses the assumption of  benefit persist if you annually pay for 
the intervention is the closest to what is being done in the RCT and also the most 
cost-effective. 
Recommendations 
Although the RCT on group education in the Cape Town context did not show all 
the beneficial effects reported in the systematic review the effect on blood pressure 
alone, if it is sustained, will prevent deaths from stroke and ischaemic heart disease 
and makes the intervention cost-effective. This study therefore supports the roll out 
of group based diabetes education in the South African context. Attention should be 
given to developing similar approaches to the other common NCDs.  The Asthma 
Guideline Implementation Project has developed group education materials for 
asthma / COPD.33 Group education should be combined with individual counselling 
and the whole package implemented in a systematic way, with further health 
services research, within the primary care health care system. 
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Conclusion 
The start-up and operational costs were calculated for this group diabetes education 
programme. Despite the initial structured group educational intervention only 
having an effect on blood pressure, the programme was found to be very cost 
effective in the South Africa context. Structured group education done by health 
promoters (mid-level health workers) with a guiding style, for patients with Type2 
diabetes mellitus in the public sector primary care facilities of the Western Cape 
represented value for money. This cost-effectiveness analysis supports the more 
widespread implementation of this intervention in primary care within South Africa. 
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